Takuo Hara

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara et al. · The Lancet Oncology · 2008 · 1.9K citations

Surgical Oncology, Spirits Trial, Gastrointestinal Oncology +8

Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas

Hua‐chuan Zheng, Hiroyuki Takahashi, Xiaohan Li et al. · Human Pathology · 2008 · 189 citations

Tumor Biology, Oncology, Gastric Carcinomas +12

Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.

Takuo Hara, Aikseng Ooi, Masaaki Kobayashi et al. · PubMed · 1998 · 185 citations

Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas

Hua‐chuan Zheng, Xiaohan Li, Takuo Hara et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2008 · 124 citations · Full text

Aggressive Features, Immunology, Gastroenterology +16

Phase <scp>II</scp> trial of nanoparticle albumin‐bound paclitaxel as second‐line chemotherapy for unresectable or recurrent gastric cancer

Yasutsuna Sasaki, Tomohiro Nishina, Hirofumi Yasui et al. · Cancer Science · 2014 · 80 citations · Full text